SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001438533-17-000034
Filing Date
2017-11-07
Accepted
2017-11-07 16:50:56
Documents
83
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rtrx-20170930x10q.htm 10-Q 1133788
2 EXHIBIT 31.1 ex09302017311.htm EX-31.1 18473
3 EXHIBIT 31.2 ex09302017312.htm EX-31.2 18553
4 EXHIBIT 32.1 ex09302017321.htm EX-32.1 11103
5 EXHIBIT 32.2 ex09302017322.htm EX-32.2 11269
12 pipelineq22017a03.jpg GRAPHIC 63570
  Complete submission text file 0001438533-17-000034.txt   6251654

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rtrx-20170930.xml EX-101.INS 1278051
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rtrx-20170930.xsd EX-101.SCH 50665
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rtrx-20170930_cal.xml EX-101.CAL 98167
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rtrx-20170930_def.xml EX-101.DEF 210005
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rtrx-20170930_lab.xml EX-101.LAB 634269
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rtrx-20170930_pre.xml EX-101.PRE 366542
Mailing Address 3721 VALLEY CENTRE DR. SUITE 200 SAN DIEGO CA 92130
Business Address 3721 VALLEY CENTRE DR. SUITE 200 SAN DIEGO CA 92130 760-260-8600
Retrophin, Inc. (Filer) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36257 | Film No.: 171184042
SIC: 2834 Pharmaceutical Preparations